1997
DOI: 10.1001/archderm.1997.03890450122020
|View full text |Cite
|
Sign up to set email alerts
|

Type of Impaired Porphyrin Metabolism Caused by Hepatitis C Virus Is Not Porphyria Cutanea Tarda but Chronic Hepatic Porphyria

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
9
0

Year Published

1999
1999
2022
2022

Publication Types

Select...
4
2
2

Relationship

0
8

Authors

Journals

citations
Cited by 10 publications
(9 citation statements)
references
References 5 publications
0
9
0
Order By: Relevance
“…HIV is associated with altered porphyrins, direct hepatic damage, impaired cytochrome oxidase, and increased estrogen levels – all of which predispose to PCT . As HIV produces increased HCV viral load, it acts synergistically to cause hepatic damage and PCT …”
Section: Chronic Hepatic Porphyriasmentioning
confidence: 99%
“…HIV is associated with altered porphyrins, direct hepatic damage, impaired cytochrome oxidase, and increased estrogen levels – all of which predispose to PCT . As HIV produces increased HCV viral load, it acts synergistically to cause hepatic damage and PCT …”
Section: Chronic Hepatic Porphyriasmentioning
confidence: 99%
“…The disorder of the body's porphyrin metabolism causes Porphyria. Atypical porphyrins have been identified in patients with acquired immunodeficiency syndrome (88). Chronic hepatic porphyria, not delayed cutaneous porphyria, is the form of porphyrin metabolic illness caused by the hepatitis C virus (88).…”
Section: Introductionmentioning
confidence: 99%
“…Atypical porphyrins have been identified in patients with acquired immunodeficiency syndrome (88). Chronic hepatic porphyria, not delayed cutaneous porphyria, is the form of porphyrin metabolic illness caused by the hepatitis C virus (88). Numerous clinical observations have revealed that patients with COVID-19 also have skin and nervous system symptoms consistent with porphyria.…”
Section: Introductionmentioning
confidence: 99%
“…Only few systematic studies on urinary porphyrin excretion, with conflicting results, have been performed in well defined groups of patients with liver diseases (5,6,(25)(26)(27)(28)(29); therefore, links between abnormal porphyrin metabolism, disease progression to cirrhosis and hepatocarcinogenesis in heptatitis C are so far unclear. In order to obtain basic epidemiological data on urinary porphyrin excretion in liver diseases for further study on prognostic implications we studied urine porphyrin excretion patterns in patients with chronic HCV infection.…”
Section: Introductionmentioning
confidence: 99%